This article is more than 5 years old. Information may no longer be current.

Alcon official: Infiniti ‘will further us in this market’

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN FRANCISCO — Alcon launched its Infiniti cataract system here at the American Society of Cataract and Refractive Surgery meeting, in what company officials say “will continue to further” the company in the market.

“What you see here is a culmination of 4 years of development, and a total investment of $40 million,” said Cary Rayment, senior vice president, Alcon United States. “We have worked closely with the ophthalmic community to advance the technology. We are convinced that the Infiniti Vision Sytem will further us in the market.”

Richard Mackool, MD, one of the surgeons who developed the technology, described the Infiniti’s three-fold capabilities. Surgeons can remove a cataract with advanced ultrasound phacoemulisification alone; with the combination of ultrasound and oscillation provided by the NeoSoniX handpiece; or with AquaLase liquefying technology.

“The Infiniti is the most technologically effective system in this market,” Dr. Mackool said. “It is the most user friendly machine I’ve ever seen, and I’ve been removing cataracts for 30 years. This system raises the bar for phacoemulsification.”